{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:22:52Z","timestamp":1793107372397,"version":"4.5.0"},"reference-count":134,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK140954"],"award-info":[{"award-number":["R01DK140954"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["T32GM135095"],"award-info":[{"award-number":["T32GM135095"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["5T32GM086330"],"award-info":[{"award-number":["5T32GM086330"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["T32CA196589"],"award-info":[{"award-number":["T32CA196589"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001797","name":"Pharmaceutical Research and Manufacturers of America Foundation","doi-asserted-by":"publisher","award":["5T32AI007151"],"award-info":[{"award-number":["5T32AI007151"]}],"id":[{"id":"10.13039\/100001797","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jconrel.2026.114906","type":"journal-article","created":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T11:17:47Z","timestamp":1775387867000},"page":"114906","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Targeted and quantitatively modeled biologic delivery via dual-functional probiotic yeast in inflammatory bowel disease"],"prefix":"10.1016","volume":"394","author":[{"given":"Anthony G.","family":"Hazelton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mairead K.","family":"Heavey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica R.","family":"Vlcek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ameya P.","family":"Chaudhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy S.","family":"Little","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Villanueva-Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaina","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sri Sruthi","family":"Potluru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allaura S.","family":"Cone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rani S.","family":"Sellers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk P.","family":"Dittmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janelle C.","family":"Arthur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliane","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jconrel.2026.114906_bb0005","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-065186","article-title":"Global, regional and national burden of inflammatory bowel disease in 204 countries and territories from 1990 to 2019: a systematic analysis based on the global burden of disease study 2019","volume":"13","author":"Wang","year":"2023","journal-title":"BMJ Open"},{"issue":"48","key":"10.1016\/j.jconrel.2026.114906_bb0010","doi-asserted-by":"crossref","first-page":"8242","DOI":"10.3748\/wjg.v27.i48.8242","article-title":"Emerging therapeutic options in inflammatory bowel disease","volume":"27","author":"Yamamoto-Furusho","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jconrel.2026.114906_bb0015","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.651415","article-title":"Novel and emerging therapies for inflammatory bowel disease","volume":"12","author":"Al-Bawardy","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"8","key":"10.1016\/j.jconrel.2026.114906_bb0020","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMct1209614","article-title":"Tumor necrosis factor inhibitors for inflammatory bowel disease","volume":"369","author":"Nielsen","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2026.114906_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.585880","article-title":"Tumor necrosis factor receptors: pleiotropic signaling complexes and their differential effects","volume":"11","author":"Gough","year":"2020","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.jconrel.2026.114906_bb0030","article-title":"Transforming growth factor-Beta signaling in cancer: therapeutic implications, challenges, and pathways to progress","volume":"4","author":"Alabi","year":"2025","journal-title":"MedComm Oncol."},{"issue":"18","key":"10.1016\/j.jconrel.2026.114906_bb0035","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.3748\/wjg.v28.i18.1922","article-title":"Novel drug delivery systems for inflammatory bowel disease","volume":"28","author":"Yasmin","year":"2022","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jconrel.2026.114906_bb0040","article-title":"Treatment of inflammatory bowel disease: a comprehensive review","volume":"8","author":"Cai","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114906_bb0045","article-title":"Managing risks with biologics","volume":"21","author":"Click","year":"2019","journal-title":"Curr. Gastroenterol. Rep. 2019 21:1"},{"issue":"5","key":"10.1016\/j.jconrel.2026.114906_bb0050","article-title":"Risks and benefits of biologic therapy for inflammatory bowel diseases","volume":"56","author":"D'Haens","year":"2007","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.jconrel.2026.114906_bb0055","doi-asserted-by":"crossref","DOI":"10.1093\/ecco-jcc\/jjy004","article-title":"Primary non-response to tumor necrosis factor antagonists is associated with inferior response to second-line biologics in patients with inflammatory bowel diseases: a systematic review and meta-analysis","volume":"12","author":"Singh","year":"2018","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.jconrel.2026.114906_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103329","article-title":"Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: current and novel biomarkers","volume":"66","author":"Cui","year":"2021","journal-title":"eBioMedicine"},{"key":"10.1016\/j.jconrel.2026.114906_bb0065","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.733992","article-title":"The gut microbiota in inflammatory bowel disease","volume":"12","author":"Qiu","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"7","key":"10.1016\/j.jconrel.2026.114906_bb0070","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41577-019-0268-7","article-title":"Host\u00f1microbiota interactions in inflammatory bowel disease","volume":"20","author":"Caruso","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114906_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2024.11.012","article-title":"Intestinal e. coli-produced yersiniabactin promotes profibrotic macrophages in crohns disease","volume":"33","author":"Ahn","year":"2025","journal-title":"Cell Host Microbe"},{"issue":"2","key":"10.1016\/j.jconrel.2026.114906_bb0080","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/ismej.2015.127","article-title":"Microorganisms linked to inflammatory bowel disease-associated dysbiosis differentially impact host physiology in gnotobiotic mice","volume":"10","author":"Hoffmann","year":"2016","journal-title":"ISME J."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114906_bb0085","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s12866-019-1610-8","article-title":"Saccharomyces boulardii alleviates ulcerative colitis carcinogenesis in mice by reducing TNF-α and IL-6 levels and functions and by rebalancing intestinal microbiota","volume":"19","author":"Wang","year":"2019","journal-title":"BMC Microbiol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114906_bb0090","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/s41598-017-01271-9","article-title":"Saccharomyces boulardii Administration changes gut microbiota and attenuates D-galactosamine-induced liver injury","volume":"7","author":"Yu","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.jconrel.2026.114906_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jof6020078","article-title":"Saccharomyces boulardii: what makes it tick as successful probiotic?","volume":"6","author":"Pais","year":"2020","journal-title":"J. Fungi"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114906_bb0100","doi-asserted-by":"crossref","DOI":"10.1186\/s12934-023-02117-y","article-title":"Improving therapeutic protein secretion in the probiotic yeast Saccharomyces boulardii using a multifactorial engineering approach","volume":"22","author":"Durmusoglu","year":"2023","journal-title":"Microb. Cell Factories"},{"issue":"5","key":"10.1016\/j.jconrel.2026.114906_bb0105","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1021\/acssynbio.0c00562","article-title":"In situ biomanufacturing of small molecules in the mammalian gut by probiotic Saccharomyces boulardii","volume":"10","author":"Durmusoglu","year":"2021","journal-title":"ACS Synth. Biol."},{"issue":"0","key":"10.1016\/j.jconrel.2026.114906_bb0110","article-title":"A yeast-based oral therapeutic delivers immune checkpoint inhibitors to reduce intestinal tumor burden","volume":"0","author":"Rebeck","year":"2024","journal-title":"Cell Chem. Biol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114906_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-017-01846-0","article-title":"Novel peptide probes to assess the tensional state of fibronectin fibers in cancer","volume":"8","author":"Arnoldini","year":"2017","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.jconrel.2026.114906_bb0120","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/MOG.0000000000000368","article-title":"The extracellular matrix in IBD: a dynamic mediator of inflammation","volume":"33","author":"Petrey","year":"2017","journal-title":"Curr. Opin. Gastroenterol."},{"issue":"10","key":"10.1016\/j.jconrel.2026.114906_bb0125","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1080\/17474124.2019.1673729","article-title":"The intestinal tissue homeostasis \u00f1 the role of extracellular matrix remodeling in inflammatory bowel disease","volume":"13","author":"Mortensen","year":"2019","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"issue":"5","key":"10.1016\/j.jconrel.2026.114906_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10051122","article-title":"The role of extracellular matrix components in inflammatory bowel diseases","volume":"10","author":"Derkacz","year":"2021","journal-title":"J. Clin. Med."},{"issue":"10","key":"10.1016\/j.jconrel.2026.114906_bb0135","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/ecco-jcc\/jjw076","article-title":"Fibrotic and vascular remodelling of colonic wall in patients with active ulcerative colitis","volume":"10","author":"Ippolito","year":"2016","journal-title":"J. Crohns Colitis"},{"issue":"11","key":"10.1016\/j.jconrel.2026.114906_bb0140","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/ecco-jcc\/jjv133","article-title":"Development of fibrosis in acute and longstanding ulcerative colitis","volume":"9","author":"de Bruyn","year":"2015","journal-title":"J. Crohn's Colitis"},{"issue":"10","key":"10.1016\/j.jconrel.2026.114906_bb0145","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.crohns.2014.03.008","article-title":"Pathophysiology of intestinal fibrosis in IBD","volume":"8","author":"Latella","year":"2014","journal-title":"J. Crohn's Colitis"},{"key":"10.1016\/j.jconrel.2026.114906_bb0150","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.609722","article-title":"Probiotic gastrointestinal transit and colonization after oral administration: a long journey","volume":"11","author":"Han","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"2","key":"10.1016\/j.jconrel.2026.114906_bb0155","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/1756283X11428502","article-title":"Efficacy and safety of the probiotic saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders","volume":"5","author":"Kelesidis","year":"2011","journal-title":"Ther. Adv. Gastroenterol."},{"issue":"2","key":"10.1016\/j.jconrel.2026.114906_bb0160","doi-asserted-by":"crossref","DOI":"10.1111\/cts.12528","article-title":"Translational development of microbiome-based therapeutics: kinetics of e. coli nissle and engineered strains in humans and nonhuman primates","volume":"11","author":"Kurtz","year":"2018","journal-title":"Clin. Transl. Sci."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114906_bb0165","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-48128-0","article-title":"Targeted delivery of the probiotic Saccharomyces boulardii to the extracellular matrix enhances gut residence time and recovery in murine colitis","volume":"15","author":"Heavey","year":"2024","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.jconrel.2026.114906_bb0170","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.tibtech.2023.01.015","article-title":"Orally delivered single-domain antibodies against gastrointestinal pathogens","volume":"41","author":"Petersson","year":"2023","journal-title":"Trends Biotechnol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114906_bb0175","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/s42003-021-02487-2","article-title":"Gastrobodies are engineered antibody mimetics resilient to pepsin and hydrochloric acid","volume":"4","author":"Wicke","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.jconrel.2026.114906_bb0180","series-title":"Single Domain Antibodies Directed against Tumour Necrosis Factor-Alpha and Uses Therefor","author":"Karen Silence","year":"2003"},{"issue":"4","key":"10.1016\/j.jconrel.2026.114906_bb0185","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1806311","article-title":"Caplacizumab treatment for acquired thrombotic thrombocytopenic purpura","volume":"380","author":"Scully","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2026.114906_bb0190","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.632687","article-title":"Immunogenicity risk profile of nanobodies","volume":"12","author":"Ackaert","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.114906_bb0195","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1429544","article-title":"Dynamics and implications of anti-drug antibodies against adalimumab using ultra-sensitive and highly drug-tolerant assays","volume":"15","author":"Ding","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.114906_bb0200","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.853008","article-title":"Ozoralizumab, a humanized anti-TNF\u03b1 NANOBODY\u00ae compound, exhibits efficacy not only at the onset of arthritis in a human TNF transgenic mouse but also during secondary failure of administration of an anti-TNF\u03b1 IgG","volume":"13","author":"Ishiwatari-Ogata","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.114906_bb0205","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01951","article-title":"Frontiers | The molecular mechanisms that underlie the immune biology of anti-drug antibody formation following treatment with monoclonal antibodies","volume":"11","author":"Vaisman-Mentesh","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.114906_bb0210","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.3389\/fmicb.2016.01504","article-title":"Stuck in the middle: fibronectin-binding proteins in gram-positive bacteria","volume":"7","author":"Hymes","year":"2016","journal-title":"Front. Microbiol."},{"issue":"2054","key":"10.1016\/j.jconrel.2026.114906_bb0215","article-title":"The multivalent role of fibronectin-binding proteins A and B (FnBPA and FnBPB) of Staphylococcus aureus in host infections","volume":"11","author":"Speziale","year":"2020","journal-title":"Front. Microbiol."},{"issue":"2433","key":"10.1016\/j.jconrel.2026.114906_bb0220","article-title":"Staphylococcal adhesion and host cell invasion: fibronectin-binding and other mechanisms","volume":"8","author":"Josse","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jconrel.2026.114906_bb0225","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/978-1-4939-2080-8_14","article-title":"Direct stochastic optical reconstruction microscopy (dSTORM)","volume":"1251","author":"Endesfelder","year":"2015","journal-title":"Methods Mol. Biol."},{"issue":"3","key":"10.1016\/j.jconrel.2026.114906_bb0230","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12191","article-title":"Imaging of surface microdomains on individual extracellular vesicles in 3-D","volume":"11","author":"McNamara","year":"2022","journal-title":"J. Extracell. Vesicles"},{"issue":"4","key":"10.1016\/j.jconrel.2026.114906_bb0235","doi-asserted-by":"crossref","DOI":"10.1111\/mmi.15203","article-title":"Super-resolution fluorescence microscopy for investigating bacterial cell biology","volume":"121","author":"Carsten","year":"2024","journal-title":"Mol. Microbiol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114906_bb0240","article-title":"Nanocluster-mediated signaling crosstalk between Fc\u03b3R and TLR4 in macrophage inflammatory responses","volume":"15","author":"Lee","year":"2025","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114906_bb0245","article-title":"Systemic localization of seven major types of carbohydrates on cell membranes by dSTORM imaging","volume":"6","author":"Chen","year":"2016","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.jconrel.2026.114906_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpj.2009.11.001","article-title":"Cell adhesion strength is controlled by intermolecular spacing of adhesion receptors","volume":"98","author":"Selhuber-Unkel","year":"2010","journal-title":"Biophys. J."},{"issue":"18","key":"10.1016\/j.jconrel.2026.114906_bb0255","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M113.543546","article-title":"Evidence for steric regulation of fibrinogen binding to Staphylococcus aureus fibronectin-binding protein a (FnBPA)","volume":"289","author":"Stemberk","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.jconrel.2026.114906_bb0260","doi-asserted-by":"crossref","DOI":"10.1002\/jmr.2768","article-title":"Sequence and structural analysis of fibronectin-binding protein reveals importance of multiple intrinsic disordered tandem repeats","volume":"32","author":"Saravanan","year":"2019","journal-title":"J. Mol. Recognit."},{"issue":"4","key":"10.1016\/j.jconrel.2026.114906_bb0265","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1208\/s12248-021-00606-9","article-title":"Modulating oral delivery and gastrointestinal kinetics of recombinant proteins via engineered fungi","volume":"23","author":"Heavey","year":"2021","journal-title":"AAPS J."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114906_bb0270","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0378-1119(93)90172-Y","article-title":"Multiple tandem integrations of transforming DNA sequences in yeast chromosomes suggest a mechanism for integrative transformation by homologous recombination","volume":"134","author":"Plessis","year":"1993","journal-title":"Gene"},{"issue":"11","key":"10.1016\/j.jconrel.2026.114906_bb0275","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2011.111","article-title":"TNF-induced necroptosis in l929 cells is tightly regulated by multiple TNFR1 complex i and II members","volume":"2","author":"Vanlangenakker","year":"2011","journal-title":"Cell Death Dis."},{"issue":"23-24","key":"10.1016\/j.jconrel.2026.114906_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2007.10.002","article-title":"The role of mechanism-based pharmacokinetic\u2013pharmacodynamic (PK\u2013PD) modelling in translational research of biologics","volume":"12","author":"Agoram","year":"2007","journal-title":"Drug Discov. Today"},{"issue":"3","key":"10.1016\/j.jconrel.2026.114906_bb0285","doi-asserted-by":"crossref","DOI":"10.1002\/cpt.2952","article-title":"A quantitative systems pharmacology model describing the cellular kinetic-pharmacodynamic relationship for a live biotherapeutic product to support microbiome drug development","volume":"114","author":"Renardy","year":"2023","journal-title":"Clin. Pharmacol. Ther."},{"issue":"11","key":"10.1016\/j.jconrel.2026.114906_bb0290","doi-asserted-by":"crossref","DOI":"10.1007\/s11095-015-1626-1","article-title":"Application of pharmacokinetic-pharmacodynamic modeling and simulation for antibody-drug conjugate development","volume":"32","author":"Singh","year":"2015","journal-title":"Pharmaceut. Res."},{"issue":"7","key":"10.1016\/j.jconrel.2026.114906_bb0295","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1007\/s10620-025-09008-9","article-title":"Engineered probiotic Saccharomyces boulardii reduces colitis-associated colorectal cancer burden in mice","volume":"70","year":"2025","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.jconrel.2026.114906_bb0300","doi-asserted-by":"crossref","DOI":"10.3389\/ffunb.2022.827704","article-title":"Frontiers | burden imposed by heterologous protein production in two major industrial yeast cell factories: identifying sources and mitigation strategies","volume":"3","author":"Kastberg","year":"2022","journal-title":"Front. Fungal Biol."},{"issue":"3","key":"10.1016\/j.jconrel.2026.114906_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2005.04.004","article-title":"Protein transport from the late golgi to the vacuole in the yeast saccharomyces cerevisiae","volume":"1744","author":"Bowers","year":"2005","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Cell Res."},{"issue":"5","key":"10.1016\/j.jconrel.2026.114906_bb0310","doi-asserted-by":"crossref","DOI":"10.1111\/j.1567-1364.2012.00810.x","article-title":"Metabolic engineering of recombinant protein secretion by saccharomyces cerevisiae","volume":"12","author":"Hou","year":"2012","journal-title":"FEMS Yeast Res."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114906_bb0315","doi-asserted-by":"crossref","DOI":"10.1002\/bit.20318","article-title":"Causes of proteolytic degradation of secreted recombinant proteins produced in methylotrophic yeast Pichia pastoris: case study with recombinant ovine interferon-\u03c4","volume":"89","author":"Sinha","year":"2005","journal-title":"Biotechnol. Bioeng."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114906_bb0320","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12934-023-02288-8","article-title":"Saccharomyces boulardii promoters for control of gene expression in vivo","volume":"23","author":"Sands","year":"2024","journal-title":"Microb. Cell Factories"},{"issue":"6","key":"10.1016\/j.jconrel.2026.114906_bb0325","doi-asserted-by":"crossref","DOI":"10.1021\/acssynbio.4c00145","article-title":"Programming probiotics: diet-responsive gene expression and colonization control in engineered S. boulardii","volume":"13","author":"Durmusoglu","year":"2024","journal-title":"ACS Synth. Biol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114906_bb0655","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/2191-219X-3-60","article-title":"Gastrointestinal transit measurements in mice with 99mTc-DTPA-labeled activated charcoal using NanoSPECT-CT","volume":"3","author":"Padmanabhan","year":"2013","journal-title":"EJNMMI Res."},{"issue":"3","key":"10.1016\/j.jconrel.2026.114906_bb0660","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1258\/la.2009.009112","article-title":"Surface area assessment of the murine intestinal tract as a prerequisite for oral dose translation from mouse to man","volume":"44","author":"Casteleyn","year":"2010","journal-title":"Lab. Anim."},{"issue":"10","key":"10.1016\/j.jconrel.2026.114906_bb0330","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1136\/gutjnl-2024-333729","article-title":"Integrated multimodel analysis of intestinal inflammation exposes key molecular features of preclinical and clinical IBD","volume":"74","author":"Gonzalez-Acera","year":"2025","journal-title":"Gut"},{"issue":"16","key":"10.1016\/j.jconrel.2026.114906_bb0335","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23169344","article-title":"Inflammatory bowel disease: a review of pre-clinical murine models of human disease","volume":"23","author":"Katsandegwaza","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.jconrel.2026.114906_bb0340","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10081903","article-title":"Characterization of maladaptive processes in acute, chronic and remission phases of experimental colitis in C57BL\/6 mice","volume":"10","author":"Gelmez","year":"2022","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114906_bb0345","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-023-04469-y","article-title":"A temporal classifier predicts histopathology state and parses acute-chronic phasing in inflammatory bowel disease patients","volume":"6","author":"Peters","year":"2023","journal-title":"Commun. Biol."},{"issue":"4","key":"10.1016\/j.jconrel.2026.114906_bb0350","doi-asserted-by":"crossref","DOI":"10.1111\/j.1440-1827.2011.02647.x","article-title":"Analysis of intestinal fibrosis in chronic colitis in mice induced by dextran sulfate sodium","volume":"61","author":"Suzuki","year":"2011","journal-title":"Pathol. Int."},{"issue":"4","key":"10.1016\/j.jconrel.2026.114906_bb0355","doi-asserted-by":"crossref","DOI":"10.15430\/JCP.2015.20.4.260","article-title":"Adequate dextran sodium sulfate-induced colitis model in mice and effective outcome measurement method","volume":"20","author":"Park","year":"2015","journal-title":"J. Cancer Prev."},{"issue":"3","key":"10.1016\/j.jconrel.2026.114906_bb0360","doi-asserted-by":"crossref","DOI":"10.1038\/s41385-019-0252-3","article-title":"The development of colitis in Il10\u2212\/\u2212 mice is dependent on IL-22","volume":"13","author":"Gunasekera","year":"2020","journal-title":"Mucosal Immunol."},{"issue":"9","key":"10.1016\/j.jconrel.2026.114906_bb0365","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044328","article-title":"Fecal lipocalin 2, a sensitive and broadly dynamic non-invasive biomarker for intestinal inflammation","volume":"7","author":"Chassaing","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114906_bb0370","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-68412-9","article-title":"Potential of using an engineered indole lactic acid producing Escherichia coli Nissle 1917 in a murine model of colitis","volume":"14","author":"Dimopoulou","year":"2024","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.jconrel.2026.114906_bb0375","doi-asserted-by":"crossref","DOI":"10.1111\/imm.12366","article-title":"Anti-mouse CD52 monoclonal antibody ameliorates intestinal epithelial barrier function in interleukin-10 knockout mice with spontaneous chronic colitis","volume":"144","author":"Wang","year":"2015","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114906_bb0380","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-64012-5","article-title":"Anti-CD81 antibodies reduce migration of activated T lymphocytes and attenuate mouse experimental colitis","volume":"10","author":"Hasezaki","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114906_bb0385","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-08915-5","article-title":"Probiotics-loaded nanoparticles attenuated colon inflammation, oxidative stress, and apoptosis in colitis","volume":"12","author":"Alkushi","year":"2022","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.jconrel.2026.114906_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2024.06.008","article-title":"TNF compromises intestinal bile-acid tolerance dictating colitis progression and limited infliximab response","volume":"36","author":"Zheng","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.jconrel.2026.114906_bb0395","article-title":"Colonic motility adjustments in acute and chronic DSS-induced colitis","volume":"321","author":"Watanabe","year":"2023","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.jconrel.2026.114906_bb0405","doi-asserted-by":"crossref","DOI":"10.1038\/labinvest.2015.32","article-title":"Recombinant human MFG-E8 ameliorates colon damage in DSS- and TNBS-induced colitis in mice","volume":"95","author":"Zhang","year":"2015","journal-title":"Lab. Investig."},{"issue":"3","key":"10.1016\/j.jconrel.2026.114906_bb0410","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/ibd.20753","article-title":"Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis","volume":"15","author":"Alex","year":"2009","journal-title":"Inflamm. Bowel Dis."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114906_bb0415","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15010222","article-title":"The effect of necrosis inhibitor on dextran sulfate sodium induced chronic colitis model in mice","volume":"15","author":"Kim","year":"2023","journal-title":"Pharmaceutics"},{"issue":"7","key":"10.1016\/j.jconrel.2026.114906_bb0420","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1093\/ecco-jcc\/jjy035","article-title":"Development of reliable, valid and responsive scoring systems for endoscopy and histology in animal models for inflammatory bowel disease","volume":"12","author":"Koelink","year":"2018","journal-title":"J. Crohn's Colitis"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114906_bb0425","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-020-02272-5","article-title":"An engineering probiotic producing defensin-5 ameliorating dextran sodium sulfate-induced mice colitis via Inhibiting NF-kB pathway","volume":"18","author":"Zeng","year":"2020","journal-title":"J. Transl. Med."},{"issue":"6","key":"10.1016\/j.jconrel.2026.114906_bb0430","article-title":"Amelioration of the DSS-induced colitis in mice by pretreatment with 4,4\u2032-diaponeurosporene-producing bacillus subtilis","volume":"14","author":"Jing","year":"2017","journal-title":"Exp. Ther. Med."},{"issue":"10","key":"10.1016\/j.jconrel.2026.114906_bb0435","doi-asserted-by":"crossref","DOI":"10.1038\/s41423-021-00760-2","article-title":"Construction of a sustainable 3-hydroxybutyrate-producing probiotic Escherichia coli for treatment of colitis","volume":"18","author":"Yan","year":"2021","journal-title":"Cell. Mol. Immunol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114906_bb0440","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3001532","article-title":"Colon stroma mediates an inflammation-driven fibroblastic response controlling matrix remodeling and healing","volume":"20","author":"Jasso","year":"2022","journal-title":"PLoS Biol."},{"issue":"8","key":"10.1016\/j.jconrel.2026.114906_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2024.03.013","article-title":"Charting the cellular biogeography in colitis reveals fibroblast trajectories and coordinated spatial remodeling","volume":"187","author":"Cadinu","year":"2024","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.jconrel.2026.114906_bb0450","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00587-19","article-title":"Yersiniabactin-producing adherent\/invasive escherichia coli promotes inflammation-associated fibrosis in gnotobiotic il10(\u2212\/\u2212) mice","volume":"87","author":"Ellermann","year":"2019","journal-title":"Infect. Immun."},{"issue":"9","key":"10.1016\/j.jconrel.2026.114906_bb0455","doi-asserted-by":"crossref","DOI":"10.1093\/ibd\/izad050","article-title":"Identification of lipocalin 2 as a potential ferroptosis-related gene in ulcerative colitis","volume":"29","author":"Deng","year":"2023","journal-title":"Inflamm. Bowel Dis."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114906_bb0460","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15384","article-title":"Inhibition of gelatinase B\/MMP-9 does not attenuate colitis in murine models of inflammatory bowel disease","volume":"8","author":"de Bruyn","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.114906_bb0465","doi-asserted-by":"crossref","DOI":"10.1002\/0471142735.im1525s104","article-title":"Dextran Sulfate Sodium (DSS)-Induced Colitis in Mice","volume":"104","author":"Chassaing","year":"2014","journal-title":"Curr. Protoc. Immunol."},{"issue":"5","key":"10.1016\/j.jconrel.2026.114906_bb0470","doi-asserted-by":"crossref","DOI":"10.1093\/ibd\/izad312","article-title":"Unveiling colitis: a journey through the dextran sodium sulfate-induced model","volume":"30","author":"Yang","year":"2024","journal-title":"Inflamm. Bowel Dis."},{"issue":"7","key":"10.1016\/j.jconrel.2026.114906_bb0475","article-title":"Gene expression profiling and response signatures associated with differential responses to Infliximab treatment in Ulcerative Colitis","volume":"106","author":"Toedter","year":"2011","journal-title":"Offl. J. Am. Coll. Gastroenterol. | ACG"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114906_bb0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107857","article-title":"GM-CSF calibrates macrophage defense and wound healing programs during intestinal infection and inflammation","volume":"32","author":"Castro-Dopico","year":"2020","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114906_bb0485","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-04098-7","article-title":"Ccr2 promotes monocyte recruitment and intestinal inflammation in mice lacking the interleukin-10 receptor","volume":"12","author":"Sayed","year":"2022","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.jconrel.2026.114906_bb0490","doi-asserted-by":"crossref","DOI":"10.1152\/ajprenal.00319.2013","article-title":"Cxcr2 knockout mice are protected against DSS-colitis-induced acute kidney injury and inflammation","volume":"305","author":"Ranganathan","year":"2013","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114906_bb0495","doi-asserted-by":"crossref","DOI":"10.1002\/ibd.20279","article-title":"Granulocyte macrophage colony stimulating factor ameliorates DSS induced experimental colitis","volume":"14","author":"Sainathan","year":"2008","journal-title":"Inflamm. Bowel Dis."},{"issue":"6","key":"10.1016\/j.jconrel.2026.114906_bb0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.01.047","article-title":"Ccl2 and CXCL12 derived from mesenchymal stromal cells cooperatively polarize IL-10+ tissue macrophages to mitigate gut injury","volume":"30","author":"Giri","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2026.114906_bb0505","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2019.02259","article-title":"Frontiers | administration of Akkermansia muciniphila ameliorates dextran sulfate sodium-induced ulcerative colitis in mice","volume":"10","author":"Bian","year":"2019","journal-title":"Front. Microbiol."},{"issue":"6","key":"10.1016\/j.jconrel.2026.114906_bb0510","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2019.1589281","article-title":"Lactobacillus fermentum species ameliorate dextran sulfate sodium-induced colitis by regulating the immune response and altering gut microbiota","volume":"10","author":"Jang","year":"2019","journal-title":"Gut Microbes"},{"issue":"3","key":"10.1016\/j.jconrel.2026.114906_bb0515","doi-asserted-by":"crossref","DOI":"10.1097\/MIB.0b013e31828028ad","article-title":"Deletion of intestinal epithelial cell STAT3 promotes t lymphocyte STAT3 activation and chronic colitis following acute dextran sodium sulfate injury in mice","volume":"19","author":"Willson","year":"2013","journal-title":"Inflamm. Bowel Dis."},{"issue":"4","key":"10.1016\/j.jconrel.2026.114906_bb0520","doi-asserted-by":"crossref","DOI":"10.4110\/in.2018.18.e30","article-title":"T cell-specific knockout of STAT3 ameliorates dextran sulfate sodium-induced colitis by reducing the inflammatory response","volume":"18","author":"Kwon","year":"2018","journal-title":"Immune Netw."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114906_bb0525","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-04041-9","article-title":"Uridine ameliorates dextran sulfate sodium (DSS)-induced colitis in mice","volume":"7","author":"Jeengar","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114906_bb0530","doi-asserted-by":"crossref","DOI":"10.1111\/j.1600-065X.2011.01018.x","article-title":"Regulatory t cells and foxp3","volume":"241","author":"Rudensky","year":"2011","journal-title":"Immunol. Rev."},{"issue":"9","key":"10.1016\/j.jconrel.2026.114906_bb0535","doi-asserted-by":"crossref","DOI":"10.1038\/ni1488","article-title":"IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways","volume":"8","author":"Zhou","year":"2007","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114906_bb0540","doi-asserted-by":"crossref","DOI":"10.1038\/ni.1818","article-title":"Regulatory T cells exert checks and balances on self tolerance and autoimmunity","volume":"11","author":"Wing","year":"2010","journal-title":"Nat. Immunol."},{"issue":"7090","key":"10.1016\/j.jconrel.2026.114906_bb0545","doi-asserted-by":"crossref","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.jconrel.2026.114906_bb0550","doi-asserted-by":"crossref","DOI":"10.1136\/gut.2007.135053","article-title":"IL23 differentially regulates the Th1\/Th17 balance in ulcerative colitis and crohns disease","volume":"57","author":"Kobayashi","year":"2008","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114906_bb0555","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-023-03263-1","article-title":"Perinatal tissue-derived exosomes ameliorate colitis in mice by regulating the Foxp3+Treg cells and gut microbiota","volume":"14","author":"Yan","year":"2023","journal-title":"Stem Cell Res. Ther."},{"issue":"5","key":"10.1016\/j.jconrel.2026.114906_bb0560","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2010.11.034","article-title":"The effects of foxp3-expressing regulatory T cells expanded with CD28 superagonist antibody in DSS-induced mice colitis","volume":"11","author":"Chen","year":"2011","journal-title":"Int. Immunopharmacol."},{"issue":"5","key":"10.1016\/j.jconrel.2026.114906_bb0565","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v19.i5.742","article-title":"Probiotics increase T regulatory cells and reduce severity of experimental colitis in mice","volume":"19","author":"Zhao","year":"2013","journal-title":"World J Gastroenterol: WJG"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114906_bb0570","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-021-02943-x","article-title":"Lactobacillus paracasei R3 protects against dextran sulfate sodium (DSS)-induced colitis in mice via regulating Th17\/Treg cell balance","volume":"19","author":"Huang","year":"2021","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114906_bb0575","article-title":"Pediococcus pentosaceus CECT 8330 protects DSS-induced colitis and regulates the intestinal microbiota and immune responses in mice","volume":"20","author":"Dong","year":"2022","journal-title":"J. Transl. Med. 2022 20:1"},{"issue":"4","key":"10.1016\/j.jconrel.2026.114906_bb0580","doi-asserted-by":"crossref","DOI":"10.1556\/EuJMI.1.2011.4.6","article-title":"The distinct roles of MMP-2 and MMP-9 in acute DSS colitis","volume":"1","author":"Heimesaat","year":"2011","journal-title":"Eur. J. Microbiol. Immunol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114906_bb0585","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcmgh.2020.07.003","article-title":"Muc2 mucin and nonmucin microbiota confer distinct innate host defense in disease susceptibility and colonic injury","volume":"11","author":"Leon-Coria","year":"2021","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"issue":"7792","key":"10.1016\/j.jconrel.2026.114906_bb0590","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1038\/d41586-020-00194-2","article-title":"The gut microbiome","volume":"577","author":"Brody","year":"2020","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.jconrel.2026.114906_bb0595","article-title":"Application of Saccharomyces boulardii in combination with sulfasalazine in ulcerative colitis patients demonstrates significant effectiveness - PubMed","volume":"17","author":"CC","year":"2025","journal-title":"World J. Gastrointest. Surg."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114906_bb0600","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-017-1175-y","article-title":"Influence of diet on the gut microbiome and implications for human health","volume":"15","author":"Singh","year":"2017","journal-title":"J. Transl. Med."},{"issue":"40","key":"10.1016\/j.jconrel.2026.114906_bb0605","article-title":"Genetically programmable self-regenerating bacterial hydrogels","volume":"31","author":"Duraj-Thatte","year":"2019","journal-title":"Adv. Mater."},{"issue":"6","key":"10.1016\/j.jconrel.2026.114906_bb0610","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201901643","article-title":"Polymeric films for the encapsulation, storage, and tunable release of therapeutic microbes","volume":"9","author":"Qiu","year":"2020","journal-title":"Adv. Healthc. Mater."},{"issue":"45","key":"10.1016\/j.jconrel.2026.114906_bb0615","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abp8798","article-title":"Mucoadhesive probiotic backpacks with ROS nanoscavengers enhance the bacteriotherapy for inflammatory bowel diseases","volume":"8","author":"Liu","year":"2022","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114906_bb0620","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abk1792","article-title":"Dynamic omnidirectional adhesive microneedle system for oral macromolecular drug delivery","volume":"8","author":"Chen","year":"2022","journal-title":"Sci. Adv."},{"issue":"43","key":"10.1016\/j.jconrel.2026.114906_bb0625","doi-asserted-by":"crossref","first-page":"9486","DOI":"10.1002\/adma.201603270","article-title":"Layer-by-layer encapsulation of probiotics for delivery to the microbiome","volume":"28","author":"Anselmo","year":"2016","journal-title":"Adv. Mater."},{"issue":"2","key":"10.1016\/j.jconrel.2026.114906_bb0630","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1039\/D5PM00288E","article-title":"Effects of microparticle composition on colony morphology and viability of encapsulated therapeutic yeast for oral delivery","volume":"3","author":"E. Etter","year":"2026","journal-title":"RSC Pharmaceut."},{"issue":"7705","key":"10.1016\/j.jconrel.2026.114906_bb0635","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-018-0092-4","article-title":"An exclusive metabolic niche enables strain engraftment in the gut microbiota","volume":"557","author":"Shepherd","year":"2018","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.jconrel.2026.114906_bb0640","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41396-021-01088-5","article-title":"Solutions in microbiome engineering: prioritizing barriers to organism establishment","volume":"16","author":"Albright","year":"2022","journal-title":"ISME J."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114906_bb0645","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nprot.2007.13","article-title":"High-efficiency yeast transformation using the LiAc\/SS carrier DNA\/PEG method","volume":"2","author":"Gietz","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jconrel.2026.114906_bb0650","article-title":"Budding yeast protein extraction and purification for the study of function, interactions, and post-translational modifications","volume":"80","author":"Szymanski","year":"2013","journal-title":"J. Vis. Exp."},{"issue":"6","key":"10.1016\/j.jconrel.2026.114906_bb0665","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.chom.2017.10.013","article-title":"Commensal fungi recapitulate the protective benefits of intestinal bacteria","volume":"22","author":"Jiang","year":"2017","journal-title":"Cell Host Microbe"},{"issue":"11","key":"10.1016\/j.jconrel.2026.114906_bb0670","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079182","article-title":"Characterization of dextran sodium sulfate-induced inflammation and colonic tumorigenesis in smad3\u2212\/\u2212 mice with dysregulated TGF\u03b2","volume":"8","author":"Seamons","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.jconrel.2026.114906_bb0675","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1093\/ecco-jcc\/jjy035","article-title":"Development of reliable, valid and responsive scoring systems for endoscopy and histology in animal models for inflammatory bowel disease","volume":"12","author":"Koelink","year":"2018","journal-title":"J. Crohn's Colitis"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926003081?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926003081?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:52:28Z","timestamp":1779756748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926003081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":134,"alternative-id":["S0168365926003081"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114906","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted and quantitatively modeled biologic delivery via dual-functional probiotic yeast in inflammatory bowel disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114906","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114906"}}